Contactin-1-associated membranous nephropathy: complete immunologic and clinical remission with rituximab

Kidney Int. 2021 Dec;100(6):1342-1344. doi: 10.1016/j.kint.2021.08.029.
No abstract available

Publication types

  • Letter
  • Comment

MeSH terms

  • Contactin 1
  • Glomerulonephritis, Membranous* / diagnosis
  • Glomerulonephritis, Membranous* / drug therapy
  • Humans
  • Immunologic Factors / therapeutic use
  • Receptors, Phospholipase A2
  • Rituximab / therapeutic use

Substances

  • Contactin 1
  • Immunologic Factors
  • Receptors, Phospholipase A2
  • Rituximab